Doctor with a microscope

Learn about Amarin

A history of innovation; a limitless future.

Clear VASCEPA® (icosapent ethyl) capsule

Amarin is a rapidly growing, innovative pharmaceutical company focused on commercializing and developing therapeutics to cost-effectively improve cardiovascular health.

Amarin’s lead product, VASCEPA, is a prescription drug. In the United States, VASCEPA is approved and marketed by Amarin’s commercial team for two indications: one for treatment of patients with very high triglyceride levels, and one for cardiovascular risk reduction in addition to medications such as statins in high-risk patients. The latter indication is new (approved by the U.S. Food and Drug Administration in December 2019 following years of development and clinical study) and VASCEPA is the only drug approved for this use.

VASCEPA follows strict regulatory standards with a patented 3-month manufacturing process qualified to meet FDA drug standards. This process ensures the consistency and stability of VASCEPA. This is important because, if damaged, the safety and efficacy of the active ingredient can vary and is highly vulnerable to derivatives and oxidation/spoilage.

VASCEPA is also available by prescription in Canada, Lebanon, and the United Arab Emirates. Amarin, together with commercial partners in select geographies, is pursuing additional regulatory approvals for VASCEPA in China, the European Union, and other regions within the Middle East.

For more information about Amarin, visit

Hand heart icon

Find out how VASCEPA can provide additional heart protection.




VASCEPA is a prescription medicine used:

  • along with certain medicines (statins) to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heart disease.
  • along with a low-fat and low-cholesterol diet to lower high levels of triglycerides (fats) in adults.

It is not known if VASCEPA changes your risk of having inflammation of your pancreas (pancreatitis).
It is not known if VASCEPA is safe and effective in children.



  • Do not take VASCEPA if you are allergic to icosapent ethyl or any of the ingredients in VASCEPA.

What are the possible side effects of VASCEPA?
VASCEPA may cause serious side effects, including:

  • Heart rhythm problems (atrial fibrillation and atrial flutter). Heart rhythm problems which can be serious and cause hospitalization have happened in people who take VASCEPA, especially in people who have heart (cardiovascular) disease or diabetes with a risk factor for heart (cardiovascular) disease, or who have had heart rhythm problems in the past. Tell your doctor if you get any symptoms of heart rhythm problems such as feeling as if your heart is beating fast and irregular, lightheadedness, dizziness, shortness of breath, chest discomfort or you faint.
  • Possible allergic reactions if you are allergic to fish or shellfish. Stop taking VASCEPA and tell your doctor right away or get emergency medical help if you have any signs or symptoms of an allergic reaction.
  • Bleeding. Serious bleeding can happen in people who take VASCEPA. Your risk of bleeding may increase if you are also taking a blood thinner medicine.
If you have liver problems and are taking VASCEPA, your doctor should do blood tests during treatment.
The most common side effects of VASCEPA include:
  • Muscle and joint pain
  • Swelling of the hands, legs, or feet
  • Constipation
  • Gout
  • Heart rhythm problems (atrial fibrillation)
These are not all the possible side effects of VASCEPA. Call your doctor for medical advice about side effects. You may report adverse events (i.e. side effects) or product complaints by contacting AmarinConnect at 1-855-VASCEPA (1-855-827-2372), emailing [email protected], or calling the FDA at 1-800-FDA-1088.

Tell your doctor if you take medicines that affect your blood clotting (anticoagulants or blood thinners).

For more information on VASCEPA, click here to see the full Patient Information or call 1-855-VASCEPA (1-855-827-2372).